In Pseudomonas aeruginosa, cyclic AMP (cAMP) signaling regulates the transcription of hundreds of genes encoding diverse virulence factors, including the type II secretion system (T2SS) and type III secretion system (T3SS) and their associated toxins, type IV pili (TFP), and flagella. Vfr, a cAMP-dependent transcriptional regulator that is homologous to the Escherichia coli catabolite repressor protein, is thought to be the major cAMP-binding protein that regulates these important virulence determinants. Using a bioinformatic approach, we have identified a gene (PA4704) encoding an additional putative cAMP-binding protein in P. aeruginosa PAO1, which we herein refer to as CbpA, for cAMP-binding protein A. Structural modeling predicts that CbpA is composed of a C-terminal cAMP-binding (CAP) domain and an N-terminal degenerate CAP domain and is structurally similar to eukaryotic protein kinase A regulatory subunits. We show that CbpA binds to cAMPconjugated agarose via its C-terminal CAP domain. Using in vitro trypsin protection assays, we demonstrate that CbpA undergoes a conformational change upon cAMP binding. Reporter gene assays and electrophoresis mobility shift assays defined the cbpA promoter and a Vfr-binding site that are necessary for Vfr-dependent transcription. Although CbpA is highly regulated by Vfr, deletion of cbpA did not affect known Vfr-dependent functions, including the T2SS, the T3SS, flagellum-or TFP-dependent motility, virulence in a mouse model of acute pneumonia, or protein expression profiles. Unexpectedly, CbpA-green fluorescent protein was found to be localized to the flagellated old cell pole in a cAMP-dependent manner. These results suggest that polar localization of CbpA may be important for its function.
Cyclic AMP (cAMP) is an evolutionarily conserved second messenger molecule that plays critical roles in signal transduction in many organisms, ranging from single-cell prokaryotes to multicellular higher eukaryotes (7, 8) . cAMP signaling pathways are initiated by the activation of adenylate cyclases in response to extracellular or intracellular stimuli (39) . In prokaryotes, the catabolite repressor protein (CRP) family of cAMP-binding proteins plays a central role in cAMP signaling (8, 26) . These molecules form homodimers composed of an N-terminal cAMP-binding (CAP) domain and a C-terminal helix-turn-helix DNA-binding domain. Upon binding of cAMP to the CAP domain, CRP family regulators undergo a conformational change that allows them to bind to specific DNA sequences at the promoters of their target genes (57) . Genome sequencing and functional studies have demonstrated that the CRP family transcriptional regulators are widely distributed in gram-negative and gram-positive bacteria, where they regulate diverse processes. These pathways include phototaxis and heterocyst formation in cyanobacteria (36) , anaerobic respiration in Shewanella oneidensis (41) , germination and morphological development in Streptomyces coelicolor (12) , Mycobacterium tuberculosis virulence in mice (40) , quorum sensing and motility in Vibrio cholerae (29) , and phytopathogenicity and cell-cell communication in Xanthomonas campestris (11, 19) .
Recent genome sequence studies have revealed that many bacterial species encode additional nucleotide cyclases and cyclic nucleotide (cNMP)-binding proteins. For example, M. tuberculosis strain H37Rv possesses 16 class III nucleotide cyclases and 10 putative cNMP-binding proteins (45) . Eight of the 10 putative cNMP-binding proteins are structurally different from typical CRP family regulators, suggesting that cAMPbinding proteins are likely to regulate far-ranging processes in prokaryotes.
The gram-negative opportunistic human pathogen Pseudomonas aeruginosa is a leading cause of acute nosocomial infections in immunocompromised patients or hospitalized individuals with epithelial injury or extensive burns, as well as the cause of chronic infections in patients with cystic fibrosis (31) . This pathogen possesses a large arsenal of cell-associated and secreted virulence factors, some of which are coordinately regulated by cAMP. The P. aeruginosa PAO1 genome encodes three adenylate cylases (48) . One of these, ExoY, is a type III secreted effector that requires a host-encoded cofactor for its activity and is presumably inactive in the bacteria (59) . In addition, a cytoplasmic adenylate cyclase, CyaA, and a membrane-localized class III adenylate cyclase, CyaB, have been identified (48, 56) . In strain PAK, the cAMP signaling pathway is initiated mainly by upregulation and activation of CyaB in response to calcium depletion or host cell contact (56) . cAMP binds and activates Vfr, an Escherichia coli CRP ortholog, leading to the expression of virulence factors important in acute infections. These include the type II secretion system MT His , or pETPA0275 His was cultured in 5 ml of LB at 37°C overnight. A 1:100 aliquot of subculture was inoculated into 100 ml of LB and grown at 37°C to an optical density at 600 nm (OD 600 ) of 0.8. Isopropyl-␤-Dthiogalactopyranoside (IPTG) was added to the culture (final concentration of 1 mM), and the culture was incubated at 20°C overnight with reciprocal shaking (300 rpm). E. coli cells were harvested by centrifugation, washed twice with chilled suspension buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, and 10% glycerol), and resuspended in suspension buffer (10 ml final volume). All of the steps for preparation of the crude protein sample were carried out on ice or at 4°C. Cells were disrupted by sonication at 10 W for 15 min (Branson sonifier 150). After removal of E. coli cell debris by centrifugation at 14,000 rpm for 15 min at 4°C, the supernatant was filtered through a 0.2-m disk filter (Millipore). The soluble fraction of the protein sample was applied to an open column (diameter ϭ 15 mm) containing 1.5 ml of cAMP-conjugated agarose resin (Sigma-Aldrich). The column was washed with 100 ml of the suspension buffer and eluted with 50 ml of elution buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 10% glycerol, and 1 mM cAMP). The eluted protein was concentrated with an Amicon Ultra-4 filter unit (Millipore) and then subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis.
SDS-PAGE and immunoblot analysis. The protein concentration was determined with a Bio-Rad protein assay (Bio-Rad Laboratories). Protein (20 g) was separated on a 12% SDS-polyacrylamide gel and transferred onto a polyvinylidene difluoride membrane (Millipore) in transfer buffer (15 mM Tris, 120 mM glycine, 20% methanol). Membranes were incubated in blocking buffer (phosphate-buffered saline [PBS] containing 5% skim milk and 0.5% Tween 20) . An anti-His 5 tag antibody (Qiagen) was used as the primary antibody at a concentration of 0.4 g/ml, while the secondary antibody, horseradish peroxidaseconjugated goat anti-mouse immunoglobulin G (IgG) (Jackson ImmunoResearch Laboratories), was used at a dilution of 1:2,000. Reactive bands were visualized using ECL Western blotting detection reagents (GE Healthcare) and were detected with an Amersham Hyperfilm ECL kit (GE Healthcare).
␤-Galactosidase assays. P. aeruginosa cultures were grown in LB broth with the appropriate antibiotics to an OD 600 of ϳ0.8. A ␤-galactosidase assay was performed as described previously (32) .
Purification of C-terminally His 6 -tagged CbpA (CbpA His ) and Vfr His . E. coli BL21(DE3) containing pETvfr His or pETcbpA His was grown in LB broth containing kanamycin at 37°C overnight. The overnight culture was diluted 1:10,000 into 100 ml of LB broth containing kanamycin and grown to an OD 600 of 0.5 to 0.8. IPTG was added to a final concentration of 0.5 mM, and the culture was further grown with shaking at 20°C overnight. Cells were harvested by centrifugation, washed twice with 30 ml of a suspension buffer (20 mM Tris-HCl, pH 7.5, 10 mM imidazole, 0.5 M NaCl, 10% glycerol), and suspended in 20 ml of suspension buffer. Cells were disrupted by sonication at 10 W for 15 min (Branson sonifier 150), and cell debris was removed by centrifugation. The supernatant was filtered through a 0.45-m filter disk and then applied to a column (diameter ϭ 15 mm) containing 2 ml of HIS-Select nickel affinity gel (Sigma-Aldrich). After the column was washed with 200 ml of suspension buffer, proteins were eluted with 50 ml of His elution buffer (20 mM Tris-HCl, pH 7.5, 300 mM imidazole, 0.5 M NaCl, 10% glycerol). The eluted fraction was then applied to a column containing 2 ml of cAMP-conjugated agarose. After the column was washed with 300 ml of His elution buffer, proteins bound to cAMPconjugated agarose were eluted with 100 ml of cAMP-BP elution buffer (20 mM Tris-HCl, pH 7.5, 300 mM imidazole, 0.5 M NaCl, 1 mM cAMP, 10% glycerol). Eluted proteins were concentrated with an Amicon Ultra-4 filter unit (Millipore) and then subjected to SDS-PAGE to confirm the purity of Vfr His or CbpA His .
Trypsin protection assay. The effects of cAMP on CbpA His conformation were determined by treating 5.6 g of CbpA His with 0.2 g trypsin for 5 min at 37°C (3, 27) . Trypsin digestion was stopped by adding 2ϫ SDS-PAGE buffer to and boiling the reaction mixture. CbpA His digested by trypsin was analyzed by SDS-PAGE.
EMSA. An electrophoresis mobility shift assay (EMSA) was performed with a digoxigenin gel shift kit (Roche Applied Science) according to the manufacturer's instruction. A 50-bp DNA fragment containing a wild-type Vfr-binding site (VBS WT ) or a mutant version (VBS MT ) was generated by PCR with sets of primers VBS-Fw and VBS-Rv or VBS MT -Rv, respectively (see Table S1 in the supplemental material). VBS WT (0.8 ng) and VBS MT (0.8 ng) were labeled with digoxigenin-11-ddUTP, and the labeled probes (0.08 ng) were mixed with purified Vfr His solution (18 or 50 ng) containing 1 mM cAMP in EMSA binding buffer containing 50 ng/l of poly(dI-dC) and 5 ng/l of poly-L-lysine. The reaction mixture was incubated for 15 min at 15 to 25°C and was subjected to electrophoresis (150 V, 10 min, 15 to 25°C) on 8% polyacrylamide gels with Tris-borate-EDTA buffer. The polyacrylamide gels were transferred to a Hybond-Nϩ (GE Healthcare) membrane and detected with a CSPD system (Roche Applied Science).
Motility and protease assays. Twitching motility was measured by Coomassie brilliant blue staining of stab assays, as previously described (53) , after 24 h of growth on LB plates poured on polystyrene dishes. For the swimming motility assay, P. aeruginosa strains were grown on LB containing 0.3% agar and appropriate antibiotics at 37°C (53) . The diameter of the swimming zone was measured after 12 h. Protease assays were performed as previously described (13) . P. aeruginosa strains were stabbed on the milk plate and grown at 37°C for 24 h. The diameter of clearing around colonies, in which milk proteins are degraded by secreted proteases from P. aeruginosa, was measured.
Cytotoxicity assays. Cytotoxicity assays were performed as described previously (53) . HeLa cells (ATCC) were plated in 24-well dishes at 5 ϫ 10 4 cells per well 48 h prior to infection. P. aeruginosa strains (PA103 derivatives) were grown overnight at 37°C in LB broth and used at a multiplicity of infection of 50. Prior to infection, HeLa cells were washed and placed in minimal essential medium. At 3 h postinfection, the entire supernatant was transferred to a tube and centrifuged at 800 rpm for 5 min to remove cell debris. Lactate dehydrogenase was measured in an aliquot of the supernatant by use of a CytoTox96 nonradioactive cytotoxicity assay kit (Promega) according to the manufacturer's instructions.
Murine model of acute pneumonia. Eight-to 12-week-old female C57BL/6 mice were housed under specific-pathogen-free conditions. Infections were carried out as described previously (4). Mice were infected intranasally with 50 l of This study pME-lacZ lacZ reporter vector, promoterless lacZ, Gm r 14 pME-P i -lacZ pME-lacZ derivative, 104-bp cbpA upstream region, Gm r This study pME-P ii -lacZ pME-lacZ derivative, 200-bp cbpA upstream region, Gm r This study pME-P ii MT -lacZ pME-lacZ derivative, 200-bp cbpA upstream region with mutations in VBS, Gm r This study pME-P iii -lacZ pME-lacZ derivative, 602-bp cbpA upstream region, Gm bacterial suspension (5 ϫ 10 7 CFU) and sacrificed 18 h postinfection. The lungs, liver, and spleen were harvested and homogenized in PBS, and bacterial counts were determined by plating serial dilutions on LB agar plates. Statistical analyses were performed using a two-tailed Mann-Whitney U test (a P value of Ͻ0.05 was considered significant). All experiments were approved by the University of California, San Francisco, Committee on Animal Research.
ExoT secretion assay. P. aeruginosa strains PA103-mini-CTX-exoT HA -lacZ, PA103⌬cbpA-mini-CTX-exoT HA -lacZ, and PA103pscJ::Tn5-mini-CTX-exoT HAlacZ (Table 1) were grown in LB broth containing 5 mM CaCl 2 or 5 mM EGTA at 37°C overnight. Cells were removed by centrifugation, and the supernatant was filtered through a 0.2-m filter disk (Millipore). Secreted proteins in the supernatant were concentrated with an Amicon Ultra-4 filter unit, separated by SDS-PAGE, and immunoblotted using mouse anti-hemagglutinin (HA) IgG (Sigma-Aldrich).
Biofilm formation assay. Biofilm formation was measured as previously described (37) , with the following modifications. Strains PAO1, PAO1⌬vfr, and PAO1⌬cbpA were grown in LB broth at 37°C overnight and diluted 1:1,000 into 2 ml of LB broth in 12-well polystyrene plates. After 24 h of incubation at 37°C, the culture supernatant was removed, each well was washed three times with 1 ml of distilled water, and the biofilm was stained with 0.05% crystal violet. After three washes with distilled water, the crystal violet-stained biofilm was dissolved by the addition of 1 ml of 99.8% ethanol, and the OD 590 of the solution was measured.
2D-PAGE. PAO1 containing pMBAD18G, PAO1⌬cbpA containing pMBAD18G, and PAO1⌬cbpA containing pMBAD-cbpA were grown in 2 ml of LB borth at 37°C overnight. The overnight culture was diluted 1:1,000 into 100 ml of LB broth containing 0.2% L-arabinose and 5 mM EGTA, and cells were grown at 37°C to an OD 600 of 1.5. Cells were harvested by centrifugation at 4°C and washed once with 50 ml of PBS. The pellet was suspended in SDS boiling buffer (5% SDS, 5% ␤-mercaptoethanol, 10% glycerol, 60 mM Tris-HCl, pH 6.8). Two-dimensional PAGE (2D-PAGE) was performed by Kendrick Labs, Inc., using the carrier ampholine method of isoelectric focusing (34) . Isoelectric focusing was carried out in glass tubes of an inner diameter of 3.5 mm, using 1% pH 4 to 6 (GE Healthcare) and 1% pH 5 to 8 (GE Healthcare) for 20 kV ⅐ h. After equilibrium in SDS sample buffer (10% glycerol, 50 mM dithiothreitol, 2.3% SDS, and 62.5 mM Tris-HCl, pH 6.8), each tube gel was sealed to the top of a stacking gel that overlays a 10% acrylamide slab gel (1.0 mm thick). SDSpolyacrylamide slab gel electrophoresis was carried out for about 5 h at 25 mA per gel. Each sample was run on duplicate gels and was scanned with a laser densitometer, model PDSI (Molecular Dynamics, Inc.). The scanner was checked for linearity prior to scanning with a calibrated neutral density filter set (Melles Griot). The images were analyzed using Progenesis PG240 software with TT900 (Nonlinear Dynamics). The general method of computerized analysis for these pairs included image warping with TT900 software followed by automatic spot finding, background subtraction (average on border), matching, and quantification in conjunction with detailed manual checking. Student's t test values for fluctuation of each spot were generated by the software for two gels.
Fluorescent microscopy. P. aeruginosa harboring green fluorescent protein (GFP)-expressing plasmids was grown at 37°C in LB broth containing 0.1% L-arabinose to an OD 600 of 1.5 to 2.0. One hundred microliters of the culture was diluted with 900 l of PBS buffer containing 2 g/ml of FM4-64FX (Invitrogen) and was incubated at room temperature for 15 min. Cells were fixed with 4% paraformaldehyde on poly-L-lysine-coated glass slides. Coverslips were mounted in Vectashield mounting media containing DAPI (4Ј,6-diamidino-2-phenylindole) (Vector Laboratories) to count the total number of bacterial cells in images. Images for all GFP fluorescence and immunofluorescence studies were acquired with a charge-coupled-device camera (Retiga) using a 100ϫ lens objective mounted on a Nikon TE2000 inverted microscope driven by Simple PCI software (Compix, Inc.). A 10ϫ ocular lens was used, making the total magnification ϫ1,000. For each set of experiments, the exposure times were identical for all images. Images were processed with Adobe Photoshop CS3. To confirm expression level and stability of CbpA-GFP and its variants, the culture used for immunofluorescent microscopy was diluted to an OD 600 of 1.0 and cytoplasmic extracts were subjected to immunoblotting using an anti-GFP antibody (Invitrogen).
Indirect immunofluorescent staining. Immunofluorescent staining for P. aeruginosa FliC was performed as previously described (33) . Briefly, P. aeruginosa PAO1⌬cbpA containing pMBAD-cbpA-GFP was grown overnight at 37°C in LB broth containing 0.1% arabinose and 5 mM EGTA. The overnight culture was diluted 1:1,000 in fresh media containing 0.1% arabinose and 5 mM EGTA and then grown at 37°C to an OD 600 of 1.5. Cells were pelleted by centrifugation and fixed in 4% paraformaldehyde for 30 min. After the cells were washed once with PBS, the cell pellets were suspended in 0.7% (wt/vol) fish scale gelatin (PBS-FSG), and the cell suspension was spotted on a poly-L-lysine-coated coverslip and incubated for 30 min at room temperature. Flagella were stained with rabbit anti-FliC polyclonal antiserum (1:100 in PBS-FSG) (kindly provided by D. Wozniak) and detected with Alexa Fluor 594-conjugated donkey anti-rabbit IgG (1:1,000 in PBS-FSG) (Invitrogen).
RESULTS
Identification of putative cAMP-binding proteins in P. aeruginosa. We carried out a BLAST-P search of the P. aeruginosa PAO1 genome for potential cAMP-binding proteins by using the CAP domain sequence (amino acids 1 to 144) of Vfr as a query. Three proteins with an E value of less than 1.0 eϪ2 were identified, i.e., Vfr, PA4704, and PA0275, with E values (bit score) of 2.0 eϪ79 (287), 2.0 eϪ7 (48.5), and 5.0 eϪ4 (37.4), respectively. BLAST-P search and alignment analysis revealed that the CAP domains of PA4704 and PA0275 showed more than 20% identity and 45% similarity to those of well-characterized cAMP-binding transcriptional regulators (Fig. 1A) . Additionally, the amino acid residues involved in direct binding of cAMP are highly conserved (Fig. 1A) .
PA0275 encodes a 228-amino-acid protein that is composed of an N-terminal CAP domain (amino acids 16 to 130) and a C-terminal, helix-turn-helix DNA-binding domain (amino acids 170 to 228) (Fig. 1B) , suggesting that the PA0275 protein may function as a cAMP-dependent transcriptional regulator.
The protein encoded by PA0275 shows 26% identity and 50% similarity to Rv3676, a cAMP-binding protein of M. tuberculosis (3).
The PA4704 gene (herein referred to as cbpA, for cAMPbinding protein A) encodes a 265-amino-acid protein composed of an N-terminal region (amino acids 1 to 132) and a C-terminal CAP domain (amino acids 133 to 265) ( Fig. 1A and B). Pfam and PROSITE database searches failed to identify any conserved domain in the N-terminal half of CbpA; however, an iterative PSI-BLAST search revealed that the region may encode a highly degenerate CAP domain (see below for details). CbpA has no identifiable signal sequence for known secretion systems. It was detectable in cell lysates under calcium-rich and calcium-limiting conditions but not in culture supernatants (data not shown), suggesting that CbpA is not secreted and is a cytoplasmic protein. cbpA is located immediately (53 bp) upstream from two genes encoding ironregulated small RNAs, prrF1 and prrF2 (Fig. 1C) , which play a crucial role in iron homeostasis by posttranscriptionally regulating expression of their target genes, including bacterioferritin (PA4880), superoxide dismutase (sodB), and anthranilate dioxygenase (antABC) genes (35, 55) . Transcription of these tandem small RNAs has been reported to be independently repressed by binding of the iron-bound form of the ferric uptake regulator (Fur) to their respective promoters (55) . Notably, a Fur box was not detected in the intergenic region between PA4703 and cbpA, suggesting that cbpA transcription may not be regulated by an iron condition. A BLAST-P search revealed that CbpA structural orthologs are found in three pseudomonads, P. stutzeri, P. fluorescens, and P. mendocina (58 to 78% identity), and in five nonpseudomonad species, Reinekea species, Cellvibrio japonicus, Hahella chejuensis, Congregibacter litoralis, and Oceanobacter species (32 to 42% amino acid identity), suggesting a conserved function. Homologs of the small iron-regulated RNAs are not always found adjacent to cbpA.
CbpA binds cAMP. To examine whether CbpA and PA0275 are bona fide cAMP-binding proteins, we tested whether they bind to cAMP. C-terminally His 6 -tagged PA0275 (PA0275 His ) and CbpA His were overexpressed in E. coli, and the soluble cell lysates were tested for binding to cAMP-conjugated agarose beads (see Materials and Methods for details). PA0275 His did not appear to bind to the cAMP column, even though it was present in the soluble fraction of the E. coli cell lysates (data not shown). In contrast, CbpA His bound to the cAMP-agarose resin and could be eluted with cAMP ( Fig. 2A) . Since PA0275 His did not bind to cAMP-agarose beads under our experimental conditions, we focused on CbpA for further analysis.
To determine whether CbpA His specifically binds to cAMPagarose beads, we tested whether it could be eluted with AMP. As shown in Fig S1 in the supplemental material, CbpA His was eluted with 1 mM cAMP but not with 1 mM AMP. To examine whether the C-terminal CAP domain of CbpA is required for binding, the Arg 207 and Ser 208 amino acid residues within the CAP domain, which are both predicted to be involved in direct binding to cAMP (18) , were changed to Ala (Fig. 1A) , and the resulting mutant protein (CbpA It has been reported that cAMP-binding proteins undergo an allosteric change in structure following the binding of cAMP (3, 27, 39) . To test whether CbpA undergoes a conformational change upon binding to cAMP, we carried out an in vitro protease digestion assay on CbpA in the presence or absence of cAMP or AMP. Purified CbpA His migrated as a 32-kDa band on SDS-polyacrylamide gels (Fig. 2C, lanes 1 to  3) and was degraded into smaller fragments after 5 min of trypsin treatment (Fig. 2C, lane 4) . The pattern of trypsin digestion products was different in the presence of cAMP but was unaffected when digestion was carried out in the presence of AMP (Fig. 2C, lanes 4, 5, and 6 ). Together, these results confirm that CbpA is a cAMP-binding protein.
Vfr directly regulates cbpA expression. Previous microarray analysis has revealed that cbpA is highly downregulated in vfr or retS mutants (17, 56) . We tested whether cbpA is a direct target of Vfr by examining its transcriptional regulation. Because cbpA is located within a cluster of six genes transcribed in the same direction (PA4701-prrF2) (Fig. 1C) were cloned into a lacZ transcriptional fusion plasmid pMElacZ, yielding pME-P i -lacZ, pME-P ii -lacZ, and pME-P iii -lacZ, respectively (Fig. 3A) . These reporter gene fusions were introduced into PAO1 and PAO1⌬vfr, and ␤-galactosidase activity was measured. The transcription from all three promoter fragments increased when the bacteria were grown in the absence of calcium, but the ␤-galactosidase activity from regions P iii and P ii was approximately five-to sixfold higher (P Ͻ 0.05) than that from the P i region (Fig. 3A) . The transcription from the P ii and P iii regions in PAO1⌬vfr was significantly reduced (P Ͻ 0.05) even under calcium-depleted conditions (Fig. 3A) . These results indicate that Vfr is necessary for the regulation of cbpA transcription and that the Vfr-responsive element localizes between the P i and P ii regions. A 21-bp consensus Vfr-binding site, 5Ј-ANWWTGNGAW NYAGWTCACAT-3Ј, where W, Y, and N represent A or T, C or T, and any nucleotide, respectively, was recently defined (22) . We identified a putative Vfr-binding sequence (VBS) (15/21 nucleotide identity) between Ϫ98 bp and Ϫ118 bp upstream of the translational start site of cbpA, which overlapped with the stop codon of PA4703 (Fig. 3B) . Three highly conserved nucleotides, 5Ј-ACA-3Ј, in the putative VBS were replaced by 5Ј-TGT-3Ј to yield pME-P ii MT -lacZ (Fig. 3B) . The ␤-galactosidase activity from pME-P ii MT -lacZ was sixfold lower (P Ͻ 0.01) than that from pME-P ii -lacZ (Fig. 3C) , indicating that the putative VBS plays an important role in the expression of cbpA. To confirm whether Vfr directly binds to the VBS, we performed an EMSA using purified Vfr His ( Fig.  3D and E) . Vfr His bound to a DNA probe (VBS WT ) composed of nucleotides Ϫ84 to Ϫ134 relative to the cbpA start codon ( Fig. 3B and E, lanes 1 to 3) . Binding was inhibited upon addition of an excess of unlabeled VBS WT (Fig. 3E, lane 4) , indicating that Vfr specifically binds to this probe. However, Vfr His was unable to bind to the VBS MT probe containing the three nucleotide mutations (Fig. 3E, lanes 5 to 7) . Together, these results demonstrate that cbpA is a direct target of Vfr.
CbpA is not necessary for known Vfr-dependent functions. Since transcription of cbpA is directly regulated by Vfr, we considered the possibility that CbpA may be involved in regulating a subset of cAMP-and Vfr-dependent events. To address the hypothesis, we constructed in-frame cbpA deletion mutants for PAO1 and PA103 as well as overexpression strains and investigated growth rate, quorum sensing-dependent protease secretion, flagellum-dependent motility, TFP-dependent twitching motility, T3SS-dependent effector secretion, host cell cytotoxicity, virulence in mice, and biofilm formation, all of which are associated with cAMP signaling through Vfr (2, 6, 10, 47, 52, 54, 56).
PAO1⌬cbpA and PA103⌬cbpA grew normally in nutrientrich media (see Fig. S2 in the supplemental material) and formed rod-shaped cells, indicating that CbpA is dispensable for replication and is not involved in regulating cell morphology. PAO1⌬cbpA grown in rich media exhibited wild-type biofilm formation (see Fig. S3 in the supplemental material), quorum sensing-dependent and T2SS-dependent protease secretion (see Fig. S4 in the supplemental material), flagellumdependent swimming motility (see Fig. S5 in the supplemental material), and TFP-dependent twitching motility (see Table S2 in the supplemental material). We also tested the role of CbpA in the virulence of P. aeruginosa PA103, a strain that produces and secretes high levels of the T3SS toxins ExoT and ExoU. We were unable to detect differences in ExoT secretion in calcium-depleted medium (see Fig. S6 in the supplemental material) or in ExoU-mediated cytotoxicity toward HeLa cells Likewise, the virulence of PA103⌬cbpA in a mouse model of pneumonia was not decreased compared to the virulence of the parental strain; at 18 h postinfection, the bacterial burdens in the lungs, spleens, and livers were not statistically significantly different (see Fig. S8 in the supplemental material). To address whether CbpA affects the expression, degradation, or modification of proteins, we performed 2D-PAGE to compare the protein expression profiles of PAO1, a cbpA mutant, and a CbpA-overexpressing strain (see Materials and Methods for details). Except for some housekeeping proteins (RNA polymerase ␤ subunit, 50S ribosomal protein, and PA2830 [HtpX], a heat shock-induced protease), no significant difference in the protein expression profiles was detected between any of these strains (see Fig. S9 in the supplemental material). These results suggest that CbpA may regulate as-yet-unknown functions in P. aeruginosa. Structural modeling of CbpA. As our results thus far failed to provide insights into the function of CbpA, we performed an additional bioinformatic analysis of the N-terminal region of CbpA. Iterative PSI-BLAST analysis demonstrated that amino acids 1 to 132 of CbpA are 47% (26%) and 35% (17%) similar (identical) to N-terminal regions (1 to 136 amino acid residues) of hypothetical proteins YP_433573 (NCBI accession no.; a 259-amino-acid protein) from H. chejuensis KCTC2396 and NP_214443 (NCBI accession no.; a 619-amino-acid protein) from "Aquifex aeolicus" VF5, respectively. The N-terminal regions (1 to 124 amino acid residues) of these proteins FIG. 3 . Transcription of cbpA is directly regulated by Vfr. (A) LacZ reporter gene assays. The schematic diagram shows cbpA and its upstream genes. The cbpA upstream regions cloned into a reporter plasmid, pME-lacZ, are indicated by the arrows. Plasmids pME-P i -lacZ, pME-P ii -lacZ, pME-P iii -lacZ, and a control plasmid, pME-lacZ, were introduced into PAO1 and PAO1⌬vfr, and ␤-galactosidase activity (act.) was measured in the presence of calcium (plus 5 mM CaCl 2 , gray bar) and in the absence of calcium (plus 5 mM EGTA, black bar). Error bars indicate standard deviation. * , P Ͻ 0.05; ** , P Ͻ 0.01 (two-tailed Student's t test). (B) A putative VBS overlaps the 3Ј end of the coding sequence of PA4703. The black box encloses the putative VBS. The nucleotides ACA at the 3Ј end of the VBS were changed to TGT in the plasmid pME-P ii MT -lacZ and in the EMSA probe VBS MT . The sequences highlighted in gray and dark gray show the regions encoding PA4703 and cbpA, respectively. (C) The VBS sequence is required for expression of cbpA. The ␤-galactosidase activities of pME-P ii -lacZ and pME-P ii MT -lacZ expressed in PAO1 were measured. Error bars indicate standard deviation. ** , P Ͻ 0.01 (two-tailed Student's t test). (D) Vfr His purification. Vfr His was expressed in E. coli BL21(DE3) and purified by two-step purification using a HIS-Select column followed by a cAMP-conjugated agarose column. (E) Vfr binds to the VBS. An EMSA was performed using purified Vfr His and DNA fragments containing VBS. VBS WT contains the DNA sequence from Ϫ85 to Ϫ134 relative to the translational start site of cbpA. An excess of unlabeled VBS WT was used as a competitor. The Vfr His gel shifts VBS WT in a dose-dependent manner but fails to shift VBS contain CAP domains, suggesting that the N-terminal region of CbpA may be composed of a degenerate CAP domain. We carried out structural modeling of CbpA using the Sequence Alignment and Modeling (SAM) system (version SAM-T06; http://compbio.soe.ucsc.edu/SAM_T06/T06-query.html) (28) and found that CbpA seems to consist of two ␤-barrel folding structures, which are typical structural folding patterns for CAP domains (see Fig. S10 in the supplemental material). We note that the predicted CbpA model is similar to the crystal structure of the protein kinase A (PKA) regulatory subunit RI␣ lacking the first 91 amino acids from Bos taurus (see Fig.  S10 in the supplemental material) (49) . CbpA exhibits polar localization. The regulatory subunits of eukaryotic PKA are anchored to specific subcellular compartments by binding to PKA-anchoring proteins and thereby play an important role in spatiotemporal regulation of the activity of PKA catalytic subunits (58) . Based on the potential structural similarity of CbpA with eukaryotic PKA regulatory subunits, we tested whether CbpA exhibits spatial localization in P. aeruginosa.
We constructed a CbpA-GFP fusion protein in which GFP was linked to the C terminus with a five-amino-acid flexible linker sequence (GGGKL). The fusion protein was placed under the control of the native cbpA promoter (the P ii region shown in Fig. 3A) . The construct was integrated as a single copy into the attB site on the chromosome of PAO1⌬cbpA. We confirmed that the CbpA-GFP fusion protein binds to cAMPconjugated agarose (data not shown), indicating that GFP did not disrupt the ability of CbpA to bind to cAMP. When PAO1⌬cbpA-mini-CTX-P ii -cbpA-gfp was grown to exponential phase, very little GFP signal was detected by fluorescence microscopy or by immunoblot analysis (data not shown). However, the CbpA-GFP fusion protein was detectable in stationary-phase-grown cells (OD 600 of 3.0 to 3.5), suggesting that CbpA levels are growth phase regulated. Strikingly, CbpA exhibited polar localization (Fig. 4A, bottom) . In the control strain PAO1⌬cbpA-mini-CTX-P ii -gfp, expressing GFP under the control of the P ii promoter from the attB site, only a diffuse cytoplasmic GFP signal was observed (Fig. 4A, top) .
Using an antibody to flagella, we next determined whether CbpA localized to a flagellated pole. As the expression level of CbpA-GFP from mini-CTX-P ii -cbpA-gfp was low even in stationary-phase cells, we constructed a multicopy plasmid, pMBAD-cbpA-gfp, that expresses the CbpA-GFP fusion protein under the control of an L-arabinose-inducible promoter (P BAD ). Induction of CbpA-GFP fusion protein expression by the addition of up to 0.1% L-arabinose did not affect growth, cell morphology, twitching motility, or swimming motility (data not shown), and CbpA-GFP was found in the soluble fraction of the cell lysates (Fig. 5C ). As shown in Fig. 4B , CbpA-GFP was concentrated mostly at the flagellated pole, though bipolar localization was observed in a small proportion of cells (data not shown). In dividing cells, CbpA-GFP foci were observed mostly at the pole distal to the division septum, suggesting that CbpA preferentially localizes to the old pole (Fig. 4B) .
We next examined whether Vfr is required for polar localization of CbpA, by expressing CbpA-GFP under an arabinose-inducible promoter in PAO1⌬vfr. There was no significant difference in the efficiency of polar localization of CbpA-GFP in PAO1⌬vfr (data not shown). These experiments suggest that while Vfr is required for CbpA transcription, it is not required for its polar localization.
The CbpA CAP domain is necessary for polar localization. To investigate which regions of CbpA are essential for polar localization, we constructed truncated variants of CbpA, CbpA⌬H, CbpA⌬B1, and CbpA⌬CAP (Fig. 5A) , and examined the localization of the C-terminal GFP fusion proteins in PAO1⌬cbpA by fluorescent microscopy. With the exception of CbpA⌬B1-GFP, the deletions did not affect the production and stability of the fusion proteins significantly (Fig. 5D) . Although the levels of CbpA⌬B1-GFP were reduced, sufficient protein was produced to allow detection by fluorescent microscopy. As shown in Fig. 5A and B, deletion of the N-terminal tandem helices (CbpA⌬H-GFP) or the first putative ␤-barrel structure, consisting of amino acid residues 38 to 105 (CbpA⌬B1-GFP), did not decrease polar localization of CbpA-GFP. Deletion of the C-terminal CAP domain (CbpA⌬CAP) abolished polar localization (Fig. 5B and C) . These studies indicate that the CAP domain of CbpA is necessary for polar localization.
cAMP binding is essential for polar localization of CbpA. In order to distinguish whether structural characteristics of the CAP domain or cAMP binding is required for polar localization of CbpA, CbpA MT fused to GFP was expressed from an arabinose-inducible promoter in PAO1⌬cbpA, and the localization of CbpA MT -GFP was investigated. Although the CAP domain mutation did not abolish the polar localization completely, the frequency of polar localization of CbpA MT -GFP was significantly decreased (37.9% of cells, n ϭ 699; P Ͻ 0.01) compared with that of the wild type (63.4%, n ϭ 1,154) (Fig.  5) ; it is possible that the substitution of only two amino acid residues conserved in the CAP domain of CbpA may not abolish its ability to bind to cAMP completely in vivo. The expression level and stability of CbpA MT -GFP were comparable to those of CbpA-GFP (Fig. 5D) . We further tested the role of cAMP by expressing CbpA-GFP in PAO1⌬cyaAB⌬ cbpA, a strain in which no cAMP is synthesized because both adenylate cyclase genes cyaA and cyaB are deleted. Note that the stability and expression level of CbpA-GFP were not affected by the deletion of cyaA and cyaB (Fig. 5D ). As shown in Fig. 6A and B, only 0.8% of cells (n ϭ 1,806) harbored CbpA-GFP foci at the cell pole. Incubation of cells with cAMP restored CbpA-GFP polar localization in ϳ40% of the cells (n ϭ 1,886, P Ͻ 0.05) (Fig. 6A and B) . These results indicate that binding of cAMP to the CAP domain is necessary and sufficient for polar localization of CbpA.
DISCUSSION
cAMP signaling in bacteria plays an important role in regulating the virulence of pathogenic microbes. Bioinformatics searches of over 1,000 bacterial species have demonstrated the presence of multiple cAMP-binding proteins with diverse domain organizations. However, no detailed studies of those cAMP-binding proteins, other than CRP family regulators, have been reported. In this study, we identified CbpA as a novel cAMP-binding protein in P. aeruginosa. Interestingly, CbpA seems to be more structurally similar to eukaryotic PKA regulatory subunits than to CRP family transcriptional regulators by virtue of the presence of an N-terminal CAP-like domain and a C-terminal CAP domain. We demonstrated that CbpA binds to cAMP via its C-terminal functional CAP domain and undergoes a conformational change upon cAMP binding. Although the N-terminal CAP-like region does not seem to be functional because of its low homology with functional CAP domains and because of the inability of CbpA MT His to bind to cAMP-agarose (Fig. 2B) , we cannot rule out the possibility that the N-terminal CAP-like domain may bind to cAMP cooperatively in conjunction with binding of cAMP to the C-terminal CAP domain. Transcription of cbpA is directly regulated by Vfr, suggesting the possibility that CbpA mediates Vfr-dependent phenotypes. However, exhaustive testing failed to reveal any differences between wild-type PAO1 or PA103 and in-frame deletions in cbpA in either of these strain backgrounds. Likewise, where examined, overexpression of CbpA did not have an apparent effect. Of particular interest is our finding that CbpA preferentially localizes to the old cell pole in a cAMP-dependent manner. We hypothesize that polar localization of CbpA may be important to its function. CbpA-like proteins in other bacteria. CbpA structural orthologs can be identified in three Pseudomonas species and five nonpseudomonad bacterial species. In addition, other proteins with a similar domain structure, comprising an N-terminal undefined region and one or two CAP domains at the C terminus, can be found in many other bacteria. One example, Rv0104 of M. tuberculosis H37Rv, encodes a 504-amino-acid protein with a C-terminal CAP domain whose transcription is predicted to be regulated by a cAMP-dependent transcriptional regulator, Rv3676 (1); its function in M. tuberculosis is (16) . One of these cAMP-binding proteins, CbpB (YP_635154; NCBI database accession no.), is a 405-amino-acid protein with C-terminal tandem CAP domains, suggesting that CbpB has two ␤-barrel structures, similar to eukaryotic PKA regulatory subunits and CbpA in P. aeruginosa. Although the molecular function of CbpB is still unknown, CbpB seems to be involved in temperature and osmotic tolerance in M. xanthus (25) . Of note, cbpA mutants of P. aeruginosa PAO1 did not exhibit temperature or osmotic sensitivity (T. Endoh and J. N. Engel, unpublished data). It will be interesting to determine whether these CbpA-like proteins exhibit distinct subcellular localization and/or change their distribution in a cAMP-dependent manner. Further studies of these CbpA-like proteins will provide clues that reveal the molecular function of those proteins and give important insights into the complexity of cAMP signaling systems in bacteria. Regulation of cbpA. Using previously identified Vfr-binding sites and mutational analysis, Kanack et al. defined a 21-bp Vfr-binding consensus sequence from which they identified 12 new potential Vfr-binding sites at upstream sites or in the intergenic regions of virulence-associated genes (22) . The list of genes whose transcription is directly regulated by Vfr has expanded to include plcN, plcHR, pbpG, prpL, algD, vfr-PA0653, argH-fimS, and pilM-ponA in addition to previously reported Vfr-binding sites upstream of toxA, toxR, lasR, and fleQ (2, 10, 22, 52). Based on our comprehensive studies, we can now add cbpA to this growing list of Vfr-regulated genes. The VBS for cbpA is 71% (15 bp) identical to the 21-bp The efficiency of polar localization was determined by the counting the number of DAPI-stained bacteria (the total cell number; see Materials and Methods) and the number of bacteria with polar CbpA-GFP, using ImageJ. Three images containing a total of at least 670 bacteria were counted for each sample. The CAP domain is required for CbpA-GFP localization. Error bars indicate standard deviation. ** , P Ͻ 0.01 (two-tailed Student's t test). (D) Steady-state protein levels of CbpA-GFP mutants. The bacteria were grown to an OD 600 of ϳ3.5, and lysates were separated by SDS-PAGE and immunoblotted with an antibody to GFP. Each variant migrates at the expected molecular mass. The expression level of CbpA⌬ B1-GFP was lower than that of other CbpA-GFP variants but could be detected after longer exposures (data not shown).
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on October 15, 2017 by guest http://jb.asm.org/ consensus sequence (Fig. 3) , suggesting that the consensus sequence can be expanded (Fig. 3) . Refining the Vfr-binding consensus sequence would help to predict direct Vfr targets out of more than 200 Vfr-regulated genes (56). While we clearly showed that cbpA transcription in PAO1 is induced by a low-calcium condition (Fig. 3A) , cbpA (PA4704) was not identified as a gene whose transcription is induced under low-calcium conditions in the extensive transcriptome analyses of P. aeruginosa strain PAK (56) . This discrepancy may reflect strain differences. Alternatively, our transcriptional analysis was carried out with a multicopy reporter plasmid, which may have enhanced the sensitivity of the assay compared to that of microarray analysis.
Several of the genes upstream of cbpA are conserved in other pseudomonads. For example, homologs of PA4703, PA4702, and PA4701 are also found in P. fluorescens, P. mendocina, and P. stutzeri. Interestingly, P. putida, "P. entofila," and P. syringae have maintained homologs of PA4701 and PA4702 but no longer encode PA4703 and/or cbpA (PA4704). The significance of the somewhat conserved nature of this locus may give clues to gene function.
CbpA is polarly localized by a cAMP-dependent mechanism. It is increasingly recognized that many bacterial complexes are polarly localized, particularly gene products involved in bacterial cell cycle, motility, and secretion systems (44) . Likewise, many bacterial signaling components are polarly localized, including proteins involved in chemosensory systems (5, 9, 51), other two-component signaling systems, and di-cyclic-GMP metabolism (21, 24, 38) . Unexpectedly, we discovered that CbpA-GFP expressed under the control of its native promoter from the chromosome or under the control of an arabinoseinducible promoter from a multicopy plasmid is polarly localized and that cAMP binding to the CAP domain is essential for the polar localization ( Fig. 5 and 6 ). Although we cannot eliminate the possibility that fusion to GFP may affect the molecular function of the native protein, we consider this unlikely because (i) CbpA-GFP bound to cAMP agarose and (ii) CbpA-GFP changes its localization in a cAMP-dependent manner. In conjunction with our results demonstrating that CbpA undergoes a conformational change upon binding cAMP, we speculate that a conformational change is required for polar localization. Whether this structural change allows the protein to bind to other proteins remains to be investigated. To the best of our knowledge, this is the first example of a bacterial protein whose subcellular localization is regulated by binding cAMP. Current studies are aimed at elucidating the physiologic role of CbpA by identifying factors required for CbpA polar localization and proteins that associate with CbpA. 
